Researchers have discovered using mice and human clinical specimens that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis (NASH), a chronic and aggressive liver condition. By identifying caspase-2's critical role, they believe an inhibitor of this enzyme could provide an effective way to stop the pathogenic progression that leads to NASH -- and possibly even reverse early symptoms.
from Top Health News -- ScienceDaily https://ift.tt/2p92cZa
No comments:
Post a Comment